Safety and effectiveness of lusutrombopag in Japanese chronic liver disease patients with thrombocytopenia undergoing invasive procedures: Interim results of a postmarketing surveillance

AIM: Lusutrombopag is approved for the treatment of thrombocytopenia in chronic liver disease patients undergoing invasive procedures. This real‐world surveillance assesses the safety and effectiveness of lusutrombopag in Japan. METHODS: This ongoing, multicenter, prospective, real‐world surveillanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Ritsue, Shiino, Chikako, Imawari, Michio, Bentley, Roy, Cai, Bin, Yoshida, Manami, Afdhal, Nezam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899664/
https://www.ncbi.nlm.nih.gov/pubmed/31228221
http://dx.doi.org/10.1111/hepr.13392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899664/
https://www.ncbi.nlm.nih.gov/pubmed/31228221
http://dx.doi.org/10.1111/hepr.13392

Ejemplares similares